Euclidean Capital LLC Q4 2025 Filing
Filed February 17, 2026
Portfolio Value
$369.4B
Holdings
12
Report Date
Q4 2025
Filing Type
13F-HR
All Holdings (12 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | VEUVANGUARD INTL EQUITY INDEX F | 2,990,084 | $219.9B | 59.53% | |
| 2 | VTVVANGUARD INDEX FDS | 520,000 | $99.3B | 26.88% | |
| 3 | INDAISHARES TR | 369,600 | $20.0B | 5.41% | |
| 4 | FHTXFOGHORN THERAPEUTICS INC | 1,573,761 | $8.5B | 2.30% | |
| 5 | ORICORIC PHARMACEUTICALS INC | 989,410 | $8.1B | 2.19% | |
| 6 | PMVPPMV PHARMACEUTICALS INC | 2,627,643 | $3.3B | 0.89% | |
| 7 | SPYSPDR S&P 500 ETF TR | 4,104 | $2.8B | 0.76% | |
| 8 | RAPTRAPT THERAPEUTICS INC | 82,234 | $2.8B | 0.75% | |
| 9 | ALECALECTOR INC | 1,307,858 | $2.0B | 0.55% | |
| 10 | SRZNSURROZEN INC | 87,696 | $2.0B | 0.54% | |
| 11 | TNYATENAYA THERAPEUTICS INC | 1,015,705 | $722.0M | 0.20% | |
| 12 | SRZNWSURROZEN INC | 170,833 | $3.0M | 0.00% |